|
|||||
|
|
| 肝癌患者肝炎病毒感染血清学标志检测的分析 | |
| 引用本文： | 杨世明,张勇萍,田榆,潘晓莉. 肝癌患者肝炎病毒感染血清学标志检测的分析[J]. 临床血液学杂志, 2008, 21(5): 521-523 |
| 作者姓名： | 杨世明 张勇萍 田榆 潘晓莉 |
| 作者单位： | 第四军医大学唐都医院输血科,西安,710038;第四军医大学唐都医院输血科,西安,710038;第四军医大学唐都医院输血科,西安,710038;第四军医大学唐都医院输血科,西安,710038 |
| 摘 要： | 目的：了解肝癌患者的肝炎病毒感染状况。方法：采用酶联免疫吸附试验（EUSA）检测了肝癌、其他肿瘤及非肿瘤患者肝炎病毒感染的血清学标志。结果：在肝癌患者中乙型肝炎（HBV）HBsAg、HBeAg、抗-HBc、丙型肝炎（抗-HCV）、丁型肝炎（抗HDV）、戊型肝炎（抗-HEV）和庚型肝炎（抗-HGV）阳性率分别为28．1％、10．7％、29．8％、13．2％、5．0％、7．4％和4．5％；其他肿瘤患者为10．1％、7．1％、12．6％、4．5％、2．0％、2．8％和2．5％；非肿瘤患者为2．5％、2．0％、3．0％、2．0％、1．5％、2．5％和2．0％。肝癌患者HBV病毒与其他肝炎病毒混合感染率为14．9％。结论：肝癌与HBV病毒感染有密切关系，其抗-HEV和抗-HDV阳性率也高于非肿瘤患者，对献血员血液及患者在输血或手术前进行肝炎病毒血清学标志的检测，是预防肝炎病毒感染和区分医患责任的重要措施。 |
| 关 键 词： | 肝炎病毒 血清学标志 肝癌患者 |
Analysis of serum marker detection in hepatocarcinoma patient with hepatitis virus infection |
|
| YANG Shiming,ZHANG Yongping,TIAN Yu,PAN Xiaoli. Analysis of serum marker detection in hepatocarcinoma patient with hepatitis virus infection[J]. Journal of Clinical Hematology, 2008, 21(5): 521-523 | |
| Authors: | YANG Shiming ZHANG Yongping TIAN Yu PAN Xiaoli |
| Affiliation: | (Department of Blood Transfusion, Tangdu Hospital, the Fourth Military Medical University, Xi＇an,710038, China) |
| Abstract: | Objective:To assess hepatitis virus infection in hepatocarcinoma patients.Method:Serum markers in patients of hepatocarcinoma,other cancer and non-cancer were detected using enzyme linked immunosorbent assay.Result:The positive rates of HBsAg,HBeAg,anti-HBc in hepatitis B,anti-HCV in hepatitis C,anti-HDV in heptitis D,anti-HEV in hepatitis E and anti-HGV in hepatitis G were 28.1%,10.7%,29.8%,13.2%,5.0%,7.4% and 4.5%,respectively in hepatocarcinoma patients;the positive rates in other cancer patients were 10... |
| Keywords: | Hepatitis virus Serum marker Hepatocarcinoma patient |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |